Concepedia

Publication | Open Access

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

217

Citations

30

References

2019

Year

Abstract

Pembrolizumab demonstrated significant antitumor activity with durable responses and a favorable safety profile in patients with advanced MF/SS.

References

YearCitations

Page 1